Oncology Based In-vivo CRO Market By Model Type (Syngeneic Models, Xenograft Models, Orthotopic Models, Genetically Engineered Models {GEMs}, and Others), By Service Type (Toxicology Testing, Efficacy Testing, Drug Discovery and Development, Pharmacokinetics and Pharmacodynamics (PK/PD), Biomarker Analysis, and Others), By Indication (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Hematological Malignancies, and Others), By End-User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutions, Government and Non-Profit Organizations, and others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035
Published Date: Dec 2024 | Report ID: MI1642 | 235 Pages
Report Coverage:
By Model Type
- Syngeneic Models
- Xenograft Models
- Orthotopic Models
- Genetically Engineered Models (GEMs)
- Others
By Service Type
- Toxicology Testing
- Efficacy Testing
- Drug Discovery and Development
- Pharmacokinetics and Pharmacodynamics (PK/PD)
- Biomarker Analysis
- Others
By Indication
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Prostate Cancer
- Hematological Malignancies
- Others
By End-User
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutions
- Government and Non-Profit Organizations
- Others
By Region
North America
- U.S.
- Canada
Europe
- U.K.
- France
- Germany
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Singapore
- Rest of Asia Pacific
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East & Africa
List of Companies:
- Charles River Laboratories
- Labcorp Drug Development
- ICON plc
- WuXi AppTec
- Parexel International
- Envigo
- Medpace
- Pharmaron
- Syneos Health
- IQVIA
- Taconic Biosciences
- Champions Oncology
- Crown Bioscience
- XenTech
- Horizon Discovery
- InVivo Biosystems
- Oncodesign
- GemPharmatech
- Eurofins Scientific
- Polaris Biotechnology
Maximize your value and knowledge with our 5 Reports-in-1 Bundle - over 40% off!
Our analysts are ready to help you immediately.